RSV & Asthma Risk in Infants: New Study Findings

by Grace Chen

RSV Infection and Maternal asthma Considerably Elevate Childhood Asthma Risk

A new study reveals a concerning link between respiratory syncytial virus (RSV) infection in infancy, especially in those hospitalized with bronchiolitis, and a substantially increased risk of developing asthma, especially when coupled with a family history of asthma or allergies. Published in Science Immunology on December 1, 2025, the research suggests that even mild RSV infections may contribute to the development of this chronic respiratory condition, perhaps underestimating the true scope of the problem.

The Interplay of Viral Infection and Allergic Predisposition

Investigators found that a mechanism involving antibody-mediated enhanced allergen uptake during viral infection explains how two key asthma risk factors – RSV infection and maternal allergy – intersect to drive increased type 2 immunity and asthma in newborns. “this mechanism of [antibody]-mediated enhanced allergen uptake mediated by viral infection helps explain how two of the best-known asthma risk factors intersect and lead to increased type 2 immunity and asthma in high-risk newborns,” researchers wrote.

How RSV Amplifies Allergic Responses

To understand this complex relationship, researchers conducted experiments using neonatal mice. They discovered that mice born to mothers with house dust mite (HDM) allergy exhibited more severe type 2 inflammation and asthma-like symptoms after being infected with pneumonia virus of mice (PVM), an analog of RSV. this was linked to the transfer of allergen-specific immunoglobulin G from mothers to their offspring, which enhanced the uptake of allergens and primed the immune system for a heightened response. Specifically, the virus upregulated Fc receptors on neonatal dendritic cells, facilitating this process.

This suggests a pathway where RSV infection doesn’t directly cause asthma, but rather exacerbates the allergic response in genetically predisposed infants. The study also demonstrated that providing RSV immunoprophylaxis to newborn mice mitigated this enhanced risk, hinting at potential preventative strategies.

Recognizing asthma in Infants: A Diagnostic Challenge

Diagnosing asthma in infants can be challenging, as symptoms often differ from those seen in adults. According to the Asthma and Allergy Foundation of America, signs of asthma in babies and toddlers can include:

  • Fast breathing
  • Visible effort in breathing (nostril flaring, exaggerated belly movement)
  • Panting during normal activities
  • Wheezing
  • Persistent coughing
  • Difficulty eating

Parents and caregivers are encouraged to share a comprehensive medical history, including family history of asthma and allergies, behavioral observations, breathing patterns, and potential triggers, to aid in accurate diagnosis.

Beyond Severe Cases: The Role of Mild RSV Infections

Until recently, the focus was primarily on severe bronchiolitis requiring hospitalization as a risk factor for asthma. Though, emerging evidence suggests that even milder RSV infections detected through broader surveillance efforts may contribute to the development of the condition.

“It was initially thought that only severe bronchiolitis requiring hospitalization was a risk factor for asthma, but recent elegant work employing surveillance hRSV detection in cohorts of newborns suggests that milder hRSV infection could also be a risk factor for asthma,” the investigators wrote. “Therefore, our study likely underestimates the true hRSV-attributable asthma risk.”

This realization underscores the need for a more comprehensive understanding of the impact of RSV across the spectrum of infection severity. The researchers acknowledge limitations in their study, such as relying on hospital-diagnosed cases, which may have missed milder instances of the virus.

Implications for Prevention and Future Research

The findings highlight the potential for preventing RSV-associated allergic asthma through interventions like maternal vaccination or immunoprophylaxis. Treating pregnant or lactating mothers with anti-RSV antibodies, as demonstrated in the mouse model, effectively blocked the development of type 2 immunity in newborns.

This research provides valuable insight into the complex interplay of maternal factors and viral infections in the development of asthma, paving the way for targeted preventative strategies to protect vulnerable infants.

Leave a Comment